Panpan Gu

China Asset Strategy Lead - Oncology @ AbbVie

About

More than 13 years working experiences in project/portfolio management across different functional teams like clinical development, regulatory affairs, and regulatory operation. PMP certified project manager with solid project management knowledge and skills.

Country

China

City

Yangpu District

Industry

Pharmaceuticals

Skill

Microsoft Office, Microsoft Excel, Microsoft Word, PowerPoint, Customer Service, English, Outlook, Public Speaking, Budgets, Editing, Strategic Planning, Negotiation, PMP certification, 制药业, 肿瘤学, 生命科学, 临床研究, 项目管理, 临床开发, 法规事务

Experience

China Asset Strategy Lead - Oncology

AbbVie

2025-11 - Present · 11 mos

Shanghai, China

AD, Program Management, R&D China and APAC Region

Takeda

2022-1 - 2025-11 · 3 yrs 11 mos

中国上海市

Senior Pipeline Project Manager, China R&D

GSK

2021-3 - 2021-12 · 10 mos

shanghai

China Oncology pipeline/project management

Project Manager

GSK

2019-3 - 2021-2 · 2 yrs

Shanghai, China

China Oncology pipeline/Project management

Project manager, China clinical Development

Boehringer Ingelheim

2017-4 - 2019-2 · 1 yr 11 mos

中国上海市区

Portfolio/pipeline/project management（Immunology & Oncology) within Clinical development team

Regulatory affairs and project management

3SBio Inc.

2016-6 - 2017-4 · 11 mos

中国上海市浦东新区

 Define filing strategy for new biologic assets in pipeline to mainstream countries like US and EU with the collaborations with external consultants (FDA former reviewers) and internal cross functional teams to . Lead/Coordinate entire IND/NDA processes.  Hold regional strategic meeting for new drug application, Solve problems during the application within company to ensure smoothly approval;  Track and analyze latest policies and regulatory development from worldwide agency site, establish and update internal regulatory database for a timely basis.

Hub Submission Manager （Asia Hub）

Pfizer

2014-6 - 2016-6 · 2 yrs 1 mo

Shangahi

Responsible for Asia regional and national regulatory submission dossier build and delivery. Drive submission coordination activities for assigned products and/or regulatory procedures as appropriate. Partnering with product teams.

CSR Coordinator

Pfizer

2012-7 - 2014-5 · 1 yr 11 mos

上海浦东新区

Project manage and coordinate compilation, quality control, approval and post-approval processes associated with development of Pfizer global Clinical study reports.

Education

Fudan University

Biology and Medicine

2020-9 - 2024-1 · 3 yrs 5 mos

Peking University

Drug Development and Regulatory Sciences

2019-3 - 2019-11 · 9 mos

The "Chinese Course on International Innovative Drug Development and Regulatory Science (CCDRS)" was jointly established in 2009 by the Peking University Clinical Research Institute, the University of California, San Francisco (UCSF), and the University of Basel, Switzerland. The course offers comprehensive, systematic, and complete insights into the entire process of innovative drug development and regulatory management, presenting the most advanced concepts and successful practices. It provides opportunities for case-based learning and face-to-face discussions with experts, helping participants master scientific, effective, economical, and forward-looking methods for drug development and regulation. The goal is to cultivate professionals in China with a thorough and systematic understanding of modern drug development and management, thereby contributing to China’s development of a competitive pharmaceutical industry.